In two previous posts, What Do You Think About Clinical Trials? and What Do You Think? Medivizor’s Clinical Trials Perception Survey Results, we learned your perceptions of clinical trials. As a follow-up, we have a short, very useful explainer video produced by the European Patients’ Academy (EUPATI) describing some of the key features of...
Read More
Home »
double-blind research
double-blind research Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Colorectal cancer
- Coronary artery disease
- Coronavirus / COVID-19
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Array
(
[0] => WP_Term Object
(
[term_id] => 1
[name] => Blog
[slug] => blog
[term_group] => 0
[term_taxonomy_id] => 1
[taxonomy] => category
[description] =>
[parent] => 0
[count] => 462
[filter] => raw
[cat_ID] => 1
[category_count] => 462
[category_description] =>
[cat_name] => Blog
[category_nicename] => blog
[category_parent] => 0
)
)
Recent Posts
- Evaluating the effectiveness of antibiotic bone cement for infected diabetic foot wounds
- Comparing the effectiveness of combined therapy of bortezomib, melphalan, and prednisone with versus without daratumumab in patients with multiple myeloma ineligible for a transplant
- Evaluating the long-term effectiveness and safety of nivolumab and AVD chemotherapy combination in patients with early-stage unfavorable classical Hodgkin lymphoma.
- Evaluating the effectiveness and safety of continuous subcutaneous foslevodopa-foscarbidopa for the treatment of motor fluctuations in patients with Parkinson’s disease.
- Comparing the effectiveness and safety of 5 injections of OnabotulinumtoxinA versus the standard 20 injections for the treatment of patients with overactive bladder.